Mediclin AG (MED.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap175.75M
Enterprise Value494.4M
P/E Ratio6.78
PEG Ratio-0.53
Price/Sales Ratio0.25
Price/Book Ratio0.75
Enterprise/Revenue0.64
Enterprise/EBITDA11.61

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.12

Income Statement

Revenue784.49M
Revenue/Share16.57
Gross Profit113.81M
EBITDA98.66M
Net Income25.49M
Diluted EPS0.54

Balance Sheet

Total Cash77.39M
Total Cash/Share1.63
Total Debt382.37M
Total Debt/Equity1.47
Current Ratio1.73
Book Value Per Share5.48

Price History

52-Week Change39.19
52-Week High4.26
52-Week Low2.88
Moving Average 50 Days4.04
Moving Average 200 Days3.73

Statistics

Average Volume6,461
Shares Outstanding47.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.97
Payout Ratio0.07
Last Split FactorN/A
Last Split DateN/A
AD